Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sesen Bio
Biotech
Carisma lightens load to stretch cash runway into Q3 2025
Carisma is leaving 37% of staffers and a clinical asset on the roadside in hopes of stretching its cash runway into the third quarter of 2025.
Gabrielle Masson
Apr 1, 2024 11:08pm
After sealing reverse merger, Carisma aims for cancer wins
Mar 21, 2023 11:20am
Sesen Bio makes up with investors in time for Valentine’s Day
Feb 14, 2023 11:00am
Spat between Sesen Bio and rival investor group boils over
Jan 26, 2023 10:51am
Sesen no more: Biotech merges with Carisma
Sep 21, 2022 10:40am
Sesen pauses phase 3 bladder cancer program to save cash
Jul 18, 2022 10:00am
